Spontaneous cervical artery dissection (sCeAD) is an uncommon vascular cause of stroke with incompletely understood pathophysiology. Altered integrity of the vascular extracellular matrix, including components of elastic fibers, has been proposed as a contributor to arterial wall vulnerability. The authors investigated whether circulating markers of elastic fiber structure—fibrillin-1 and soluble elastin fragments (sELF)—differ in patients with acute sCeAD compared with patients with non-CeAD ischemic stroke and healthy controls, and whether concentrations change during recovery.
This was a prospective multicenter study carried out at four German stroke centers. Patients with acute sCeAD were enrolled consecutively and provided blood samples at baseline (acute presentation) and at follow-up after 6 ± 1 months. Two comparator groups were included: patients with a first acute ischemic stroke not related to sCeAD, and healthy individuals. The analysis included 61 patients with sCeAD, 53 patients with first non-CeAD ischemic stroke, and 79 healthy controls. Sex-matching was applied for relevant comparisons.
Serum concentrations of fibrillin-1 and sELF were measured using enzyme-linked immunosorbent assays (ELISAs). The study compared median concentrations and interquartile ranges across groups, examined sex-stratified differences, and assessed within-patient changes between the acute baseline sample and the 6-month follow-up sample in the sCeAD cohort. Statistical significance for reported comparisons is taken from the source results.
After sex-matching, patients with acute sCeAD had significantly lower serum fibrillin-1 concentrations than healthy controls. Reported median concentrations were 97 ng/mL (interquartile range 60–192) in the acute sCeAD group versus 176 ng/mL (113–269) in healthy controls (p = 0.009). This difference was observed when comparing overall sex-matched groups and when stratifying by sex: both male and female patients with sCeAD showed lower fibrillin-1 compared with their respective healthy counterparts.
Measurements of sELF did not reveal significant differences between the sCeAD group, the non-CeAD ischemic stroke group, and healthy controls. Likewise, sELF concentrations did not show significant changes between the acute baseline and the 6-month follow-up within the sCeAD cohort according to the source report.
Across all study groups, serum fibrillin-1 concentrations were higher in men than in women. Despite this overall sex difference, the acute reduction in fibrillin-1 in sCeAD was present in both sexes when compared to sex-matched healthy controls. The authors emphasize that pronounced sex-related differences in fibrillin-1 highlight the need for sex-specific analyses in future biomarker studies of sCeAD.
In the sCeAD cohort, serum fibrillin-1 concentrations increased significantly at follow-up compared with baseline. Median fibrillin-1 rose from 104 ng/mL (67–205) at the acute time point to 171 ng/mL (130–270) at approximately 6 months (p = 0.021). This pattern indicates a transient reduction of circulating fibrillin-1 during the acute phase of sCeAD with partial or full recovery by the chronic time point captured in this study.
The study received approval from the local ethics committee of the Medical Faculty at the University of Leipzig (reference number 410/18-ek). The authors declare no competing interests. The dataset underlying the study is available from the corresponding author on reasonable request. As a preprint, the report has not been peer-reviewed; the source cautions that findings should not yet guide clinical practice. The available source text does not provide further methodological detail such as assay characteristics, adjustment for potential confounders, or comprehensive inclusion/exclusion criteria beyond the groups described; those details were not reported in the provided source excerpt.
This prospective multicenter study reports a transient, sex-specific reduction in circulating fibrillin-1 concentrations during acute sCeAD, with concentrations increasing over a 6-month interval. No differences or temporal changes were detected for sELF. The findings support an association between circulating fibrillin-1 and the acute phase of sCeAD and underscore the importance of conducting sex-specific analyses in future research. The authors conclude that further investigation is warranted to clarify whether altered fibrillin-1 is causally related to sCeAD pathophysiology or reflects an acute-phase phenomenon, and to explore potential diagnostic or prognostic utility; additional details and peer review are needed before clinical application.